DELIVERY OF AN AGENT USING IONTOPHORESIS

• US 20070299420A1
• Filed: 01/18/2007
• Published: 12/27/2007
• Est. Priority Date: 06/23/2006
• Status: Abandoned Application

• Current Assignee: Minu, LLC
• Original Assignee: Minu, LLC
• Inventors: Peyman, Gholam A.
• Application Number:
  US11/624,400
• Publication Number:
  US 20070299420A1
• Time in Patent Office: Days
• US Class Current: 604/501
• CPC Class Codes: A61N 1/30 Apparatus for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body, or cataphoresis
• CPC Class Codes: A61N 1/36046 of the eye

Abstract

A method and apparatus for delivering an agent to structures of the eye or other body sites using iontophoresis applied through the eyelid, skin, etc. of a patient. A drug is introduced into the eye or other body site. A first electrode is in electrical communication with the site and a second electrode is positioned in relation to the first electrode. The electrodes are energized to generate a current between the electrodes and through the site that facilitates the selective dissemination of the agent throughout the eye or site.

Claims

1. A method for delivering an agent to a body site using iontophoresis, the method comprising:

providing an agent in a controlled release formulation at or in proximity to a body site of an individual,

positioning a first electrode at or in proximity to the site, the first electrode having a housing having an inner surface adapted to be in electrical communication with the site, and having an outer surface opposite the inner surface, and a second electrode in electrical communication with the site, the second electrode adapted to cooperate with the first electrode such that current passes between the first and second electrodes and through the site when the first electrode is in electrical communication with the power source, and

regulating electrical communication between the electrodes to alter agent release from the formulation into the site.

2. The method of claim 1 wherein the individual controls regulation.

3. The method of claim 1 wherein a medical practioner controls regulation.

4. The method of claim 1 wherein a medical practioner controls regulation at a site remote from the individual.

5. The method of claim 1 wherein agent release is increased or decreased.

6. The method of claim 1 wherein the agent is provided to the site by at least one of injection, implantation, topical administration, or transdermal administration.

7. The method of claim 1 wherein the body site is at least one of skin, eye, nose, mouth, or ear.

8. The method of claim 1 wherein the controlled release formulation is at least one of microparticles, microcapsules, nanoparticles, nanocapsules, or liposomes.

9. The method of claim 1 wherein agent is released from a housing of the first electrode, the housing adapted as a reservoir for agent in fluid communication with the inner surface of the housing.

10. The method of claim 9 wherein agent is released from a housing of the first electrode configured as a patch.

11. The method of claim 9 wherein agent is released from the inner surface of the housing operating as an adjustable barrier and having at least one aperture for permitting fluid communication between the reservoir and the body site to introduce the agent into the site.

12. The method of claim 9 wherein the reservoir is separated into at least two compartments each containing an agent, the release of agent from each of the compartments being independently controlled.

13. The method of claim 9 wherein agent is released from at least of a housing having controlled release properties or a reservoir having controlled release properties.

14. The method of claim 1 wherein the agent is selected from the group consisting of an antibiotic, anti-inflammatory, anti-proliferative, hormone, cytokine, growth factor, antibody, immune modulator, vector for gene therapy, oligonucleotide, enzyme, enzyme inhibitors, and combinations thereof.

15. A method for providing an agent to a body site using iontophoresis, the method comprising

providing an agent in a controlled release formulation at or in proximity to a body site of an individual,

positioning a first electrode at or in proximity to the site, the first electrode having a housing having an inner surface adapted to be in electrical communication with the site, and having an outer surface opposite the inner surface, and a second electrode in electrical communication with the site, the second electrode adapted to cooperate with the first electrode such that current passes between the first and second electrodes and through the site when the first electrode is in electrical communication with the power source, and

regulating electrical communication between the electrodes to provide a desired gradient of agent from the site at which agent is provided to the body site to be treated.

16. The method of claim 16 wherein the body site is the eye.

17. The method of claim 16 wherein a natural gradient of agent is increased by iontophoresis.

18. The method of claim 16 wherein a natural gradient of agent is decreased by iontophoresis.

19. The method of claim 16 wherein agent is provided in a controlled release formulation.